Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Bridging progestogens in pregnancy and pregnancy prevention.

Micks E, Raglan GB, Schulkin J.

Endocr Connect. 2015 Dec;4(4):R81-92. doi: 10.1530/EC-15-0093. Review.

2.

STOPPIT Baby Follow-up Study: the effect of prophylactic progesterone in twin pregnancy on childhood outcome.

McNamara HC, Wood R, Chalmers J, Marlow N, Norrie J, MacLennan G, McPherson G, Boachie C, Norman JE.

PLoS One. 2015 Apr 16;10(4):e0122341. doi: 10.1371/journal.pone.0122341. eCollection 2015.

3.

Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.

Feghali M, Venkataramanan R, Caritis S.

Semin Perinatol. 2014 Dec;38(8):516-22. doi: 10.1053/j.semperi.2014.08.013. Epub 2014 Sep 23. Review.

4.

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth.

Vidaeff AC, Belfort MA.

Patient Prefer Adherence. 2013 Jul 11;7:683-91. doi: 10.2147/PPA.S35612. Print 2013.

5.

Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.

Caritis SN, Sharma S, Venkataramanan R, Hankins GD, Miodovnik M, Hebert MF, Umans JG, Benedetti T, Mattison D, Zajicek A, Fischer D, Jackson A; Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetrical-Fetal Pharmacology Research Units Network.

Am J Obstet Gynecol. 2012 Nov;207(5):398.e1-8. doi: 10.1016/j.ajog.2012.08.015. Epub 2012 Aug 16.

7.

Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?

Norman JE, Shennan A, Bennett P, Thornton S, Robson S, Marlow N, Norrie J, Petrou S, Sebire N, Lavender T, Whyte S.

BMC Pregnancy Childbirth. 2012 Aug 6;12:79. doi: 10.1186/1471-2393-12-79.

8.

Outcome of vaginal progesterone as a tocolytic agent: randomized clinical trial.

Saleh Gargari S, Habibolahi M, Zonobi Z, Khani Z, Sarfjoo FS, Kazemi Robati A, Etemad R, Karimi Z.

ISRN Obstet Gynecol. 2012;2012:607906. doi: 10.5402/2012/607906. Epub 2012 May 23.

9.

Progestin treatment for the prevention of preterm birth.

Lucovnik M, Kuon RJ, Chambliss LR, Maner WL, Shi SQ, Shi L, Balducci J, Garfield RE.

Acta Obstet Gynecol Scand. 2011 Oct;90(10):1057-69. doi: 10.1111/j.1600-0412.2011.01178.x. Epub 2011 Jun 27. Review.

10.

Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth.

Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, Husslein P, Lamont R, Mikhailov A, Montenegro N, Radunovic N, Robson M, Robson SC, Sen C, Shennan A, Stamatian F, Ville Y.

J Matern Fetal Neonatal Med. 2011 May;24(5):659-67. doi: 10.3109/14767058.2011.553694. Epub 2011 Mar 2. No abstract available.

11.

Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

Zegels G, Van Raemdonck GA, Tjalma WA, Van Ostade XW.

Proteome Sci. 2010 Dec 8;8:63. doi: 10.1186/1477-5956-8-63.

12.

The role of progesterone in prevention of preterm birth.

Dodd JM, Crowther CA.

Int J Womens Health. 2010 Aug 9;1:73-84.

13.

Care for women with prior preterm birth.

Iams JD, Berghella V.

Am J Obstet Gynecol. 2010 Aug;203(2):89-100. doi: 10.1016/j.ajog.2010.02.004. Epub 2010 Apr 24. Review.

14.

Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety.

How HY, Sibai BM.

Ther Clin Risk Manag. 2009 Feb;5(1):55-64. Epub 2009 Mar 26.

Items per page

Supplemental Content

Write to the Help Desk